41789-70-2 Usage
Uses
Used in Pharmaceutical Industry:
5-Phenyl-1H-azepin-2(3H)-one is used as a structural component for the design of bioactive molecules due to its unique ring structure and the presence of a phenyl group. Its potential in the development of new pharmaceuticals is attributed to its ability to be incorporated into various drug molecules, enhancing their therapeutic effects.
Used in Organic Synthesis:
As a building block, 5-Phenyl-1H-azepin-2(3H)-one is utilized in the synthesis of a range of organic compounds. Its structural versatility allows for the creation of diverse chemical entities, which can be further modified to achieve desired properties and functions in various applications.
Used in Antimicrobial Applications:
5-Phenyl-1H-azepin-2(3H)-one may be employed as an antimicrobial agent, given its potential to exhibit biological activities against various microorganisms. Its use in this application could contribute to the development of new antimicrobial drugs to combat resistant strains and infections.
Used in Anti-inflammatory and Analgesic Applications:
Although further research is required, 5-Phenyl-1H-azepin-2(3H)-one may also be used as an anti-inflammatory and analgesic agent. Its potential in these applications could be attributed to its ability to modulate inflammatory pathways and provide pain relief, making it a candidate for the development of new medications in these therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 41789-70-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,7,8 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 41789-70:
(7*4)+(6*1)+(5*7)+(4*8)+(3*9)+(2*7)+(1*0)=142
142 % 10 = 2
So 41789-70-2 is a valid CAS Registry Number.
41789-70-2Relevant academic research and scientific papers
AZEPINE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS
-
Page/Page column 7-8, (2009/04/25)
Compounds of formula (I), pharmaceutical compositions comprising them, and methods for their use are described.
